Wednesday, September 23, 2026

Silicom Ltd And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

November 28, 2021

Silicom Ltd  And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Silicom Ltd (SILC), The Ensign Group (ENSG), ManpowerGroup (MAN) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Silicom Ltd (SILC)

16% sales growth and 5.15% return on equity

Silicom Ltd., together with its subsidiaries, designs, manufactures, markets, and supports networking and data infrastructure solutions for a range of servers, server-based systems, and communications devices in North America, Europe, and the Asia Pacific.

Silicom Ltd's sales growth this year is expected to be 18.2% and 16.6% for next year.

Year-on-year quarterly revenue growth grew by 15.8%, now sitting on 126.06M for the twelve trailing months.

Volume

Today's last reported volume for Silicom Ltd is 8683 which is 59.75% below its average volume of 21573.

Silicom Ltd's sales growth for the next quarter is 16%. The company's growth estimates for the current quarter and the next is 1.8% and 9.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.15%.

Volatility

Silicom Ltd's last day, last week, and last month's current intraday variation average was 0.27%, 0.70%, and 2.08%, respectively.

Silicom Ltd's highest amplitude of average volatility was 1.17% (day), 2.31% (last week), and 3.98% (last month), respectively.

Silicom Ltd's Stock Yearly Top and Bottom Value

Silicom Ltd's stock is valued at $44.58 at 10:22 EST, way below its 52-week high of $59.27 and way higher than its 52-week low of $36.02.

Silicom Ltd's Moving Average

Silicom Ltd's worth is above its 50-day moving average of $42.68 and above its 200-day moving average of $43.97.

2. The Ensign Group (ENSG)

11.8% sales growth and 22.34% return on equity

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses.

The Ensign Group's sales growth this year is anticipated to be 9.5% and 9.8% for next year.

Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 2.56B for the twelve trailing months.

Volume

Today's last reported volume for The Ensign Group is 202089 which is 19.55% below its average volume of 251204.

The Ensign Group's sales growth for the next quarter is 11.8%. The company's growth estimates for the ongoing quarter and the next is 20% and 9.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.34%.

Volatility

The Ensign Group's last day, last week, and last month's current intraday variation average was 0.62%, 1.14%, and 2.01%, respectively.

The Ensign Group's highest amplitude of average volatility was 1.42% (day), 2.28% (last week), and 3.31% (last month), respectively.

The Ensign Group's Stock Yearly Top and Bottom Value

The Ensign Group's stock is valued at $81.16 at 10:22 EST, way under its 52-week high of $98.66 and way higher than its 52-week low of $68.29.

The Ensign Group's Moving Average

The Ensign Group's value is higher than its 50-day moving average of $76.55 and under its 200-day moving average of $83.42.

3. ManpowerGroup (MAN)

8% sales growth and 13.66% return on equity

ManpowerGroup Inc. provides workforce solutions and services in the Americas, Southern Europe, Northern Europe, and the Asia Pacific Middle East region.

ManpowerGroup's sales growth this year is anticipated to be 16.5% and 5.2% for next year.

Year-on-year quarterly revenue growth grew by 12.1%, now sitting on 20.4B for the twelve trailing months.

Volume

Today's last reported volume for ManpowerGroup is 368148 which is 0.87% below its average volume of 371380.

ManpowerGroup's sales growth for the next quarter is 8%. The company's growth estimates for the current quarter and the next is 58.3% and 37.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.66%.

Volatility

ManpowerGroup's last day, last week, and last month's current intraday variation average was 0.76%, 1.08%, and 1.16%, respectively.

ManpowerGroup's highest amplitude of average volatility was 2.00% (day), 2.41% (last week), and 2.03% (last month), respectively.

ManpowerGroup's Stock Yearly Top and Bottom Value

ManpowerGroup's stock is valued at $99.10 at 10:22 EST, way under its 52-week high of $125.07 and way above its 52-week low of $85.97.

ManpowerGroup's Moving Average

ManpowerGroup's value is under its 50-day moving average of $106.79 and way below its 200-day moving average of $111.43.

4. Zoetis (ZTS)

8% sales growth and 51.94% return on equity

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally.

Zoetis's sales growth this year is anticipated to be 15.1% and 8.3% for next year.

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 7.41B for the twelve trailing months.

Volume

Today's last reported volume for Zoetis is 1672390 which is 16.45% above its average volume of 1436060.

Zoetis's sales growth is a negative 0% for the current quarter and 8% for the next. The company's growth estimates for the present quarter and the next is 0.9% and 11%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.94%.

Volatility

Zoetis's last day, last week, and last month's current intraday variation average was 1.76%, 0.72%, and 0.95%, respectively.

Zoetis's highest amplitude of average volatility was 3.41% (day), 2.21% (last week), and 1.77% (last month), respectively.

Zoetis's Stock Yearly Top and Bottom Value

Zoetis's stock is valued at $225.54 at 10:22 EST, higher than its 52-week high of $220.81.

Zoetis's Moving Average

Zoetis's worth is above its 50-day moving average of $205.04 and way higher than its 200-day moving average of $194.49.

5. Martin Marietta Materials (MLM)

7.9% sales growth and 13.23% return on equity

Martin Marietta Materials, Inc., a natural resource-based building materials company, supplies aggregates and heavy building materials to the construction industry in the United States and internationally.

Martin Marietta Materials's sales growth this year is expected to be 10.2% and 7.7% for next year.

Year-on-year quarterly revenue growth grew by 8.9%, now sitting on 4.57B for the twelve trailing months.

Volume

Today's last reported volume for Martin Marietta Materials is 278677 which is 13.88% below its average volume of 323604.

Martin Marietta Materials's sales growth for the next quarter is 7.9%. The company's growth estimates for the present quarter and the next is a negative 8.5% and negative -3.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.23%.

Volatility

Martin Marietta Materials's last day, last week, and last month's current intraday variation average was 1.94%, 0.80%, and 1.02%, respectively.

Martin Marietta Materials's highest amplitude of average volatility was 1.99% (day), 1.72% (last week), and 2.19% (last month), respectively.

Martin Marietta Materials's Stock Yearly Top and Bottom Value

Martin Marietta Materials's stock is valued at $420.25 at 10:22 EST, under its 52-week high of $435.62 and way above its 52-week low of $258.18.

Martin Marietta Materials's Moving Average

Martin Marietta Materials's value is way higher than its 50-day moving average of $375.16 and way above its 200-day moving average of $365.94.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com